You might like
It’s so tragic how anytime I see a post about ALS, or get a like from someone, I click there account and see they either have ALS or have a family member with ALS. To everyone else: Please, care.
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS ir.brainstorm-cell.com/2023-10-18-Bra…
We are sharing our way forward! We stay committed to do all we can to make this happen. We will align with the @US_FDA to provide the data needed. Join us on the call today @8:30am for more details: ir.brainstorm-cell.com/2023-10-18-Bra…
It’s heartbreaking for those who don’t have the time to wait. Truly, I’m sorry. All things how they are now, I want the advocacy groups to stay out of it and Brainstorm to design the trial 100% based on what the FDA wants. GIVE THEM WHAT THEY WANT. So #Nurown can be approved
Dr. Windebank, @MayoClinic Neurology Chairman: 40+ yrs of clinical & research experience with #ALS @FDACBER NUROWN AdCom: "I have clearly seen some people STABILIZE in a way that I've NEVER seen IN ANY OTHER TRIAL" CONGRESS & @DrCaliff_FDA, PLEASE listen below. Will you allow…
“This is a disease altering medication that patients with #ALS would benefit from right now. "
Northwestern #neurologist supports #NurOwn's approval: "#Debamestrocel is supported by clinical data, real world data & first-in-class biomarker data... It has been shown to slow progression of #ALS, with some lucky patients actually regaining some motor function. Please…
In all due respect, it seems straightforward to approve #NurOwn, whose benefit to risk ratio is high. ~ Dr Marc Lenaerts, MD Vice Chair #Neurology at UC Davis with 30+ yrs experience #NurOwnWorks #NurOwnPreservesFunction🛟 #ALS #neurotwitter regulations.gov/comment/FDA-20… @FDACBER…
Successful, credible, honest, beautiful. Tragically, now gone because of a 3+ year debate that should never have been. If denying terminal #ALS patients even one hope with significant data, safety, and such obvious clinical outcomes isn't a stain on a civilized society, what…
36-year-old Eddie died of #ALS WITH NO CHANCE OF SURVIVAL >90% of people with HORRIFIC 100% FATAL #ALS have no family history. You or your loved one could be next CONGRESS, DEMAND an END to the CRUEL @FDACBER regulatory RIGIDITY. @DrCaliff_FDA, grant #NUROWN Accelerated…
I would like to draw attention to @alsadvocacy Cathy who I believe has been & continues to be a major obstacle to #ALS progress. MARK MY WORDS. Cathy has & will continue to do everything possible to prevent Nurown approval. She recently cleverly posed a FALSE question (below)…
Details regarding the #FDA #AdComm for #NurOwn are now posted and the docket is open for public comments. Read more about the Advisory Committee Meeting September 27, 2023 Announcement - 09/27/2023 | FDA fda.gov/advisory-commi…
39-year-old Justin died of #ALS leaving behind his wife & young daughter @DrCaliff_FDA, PLEASE explain to his daughter why he had to die denied #NUROWN through the same #AcceleratedApproval pathway that allowed your mom to live longer despite her multiple myeloma. #NurownWorks…
I've known Cathy, who ironically calls herself "@alsadvocacy", for a decade through the ALS forums. I believe that Cathy is a MAJOR obstacle to progress in ALS. Always has been. MARK MY WORDS. Cathy has, & will continue to do everything possible to prevent #Nurown approval.…
🚨PAPAS ALL OR NOTHIN GIVEAWAY🚨 You know the rules:📋 -If this ticket goes 6/6 I do a giveaway to 6 followers 🗣🆓 -if this ticket goes 0/6 I do a giveaway to 6 followers 🗣🆓 Just LIKE/RT to enter 👍🏼 🔁 (Must be following @PrizePicksPapa) GOOD LUCK 🍀 ⬇️Pays 30X⬇️
I was diagnosed with ALS at 35, before I was able to start a family. I see some in the later stages of #ALS derive some joy in watching their children grow up. I can't remember the last time I felt joy or looked forward to tomorrow. Still, I somehow have hope for brighter…
This is what we've all been waiting for! #Nurown is the only thing that I have found a hope in at this point! #fda please approve and give us all a chance!
Happy to announce that the FDA notified us that the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) will review NurOwn September 27, 2023. PDUFA target action date set to occur by December 8, 2023 prnewswire.com/news-releases/…
prnewswire.com
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review NurOwn® Biologics...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
We are pleased to announce the #FDA #AdComm for #NurOwn will be held on Sept. 27. Read more here: ir.brainstorm-cell.com/2023-06-06-Bra…
United States Trends
- 1. Harbaugh 93,8 B posts
- 2. #WWENXT 3.809 posts
- 3. Usha 9.460 posts
- 4. Ravens 91,3 B posts
- 5. Greenland 422 B posts
- 6. Monken 6.537 posts
- 7. #RHOSLC 3.136 posts
- 8. #NewYearsEvil 2.490 posts
- 9. Lamar 36,2 B posts
- 10. Markstrom N/A
- 11. Giants 46 B posts
- 12. Ashli Babbitt 110 B posts
- 13. Michael Reagan 4.553 posts
- 14. Capitol 331 B posts
- 15. Flores 142 B posts
- 16. Sherman 7.328 posts
- 17. Drysdale N/A
- 18. Meredith 2.639 posts
- 19. Zegras 2.664 posts
- 20. Harbs 2.493 posts
Something went wrong.
Something went wrong.